| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |